Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial
Gespeichert in:
| Weitere Verfasser: | , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
2011
|
| In: |
Archives of neurology
Year: 2011, Jahrgang: 68, Heft: 10, Pages: 1245-1251 |
| ISSN: | 0003-9942 |
| Online-Zugang: |
|
| Verfasserangaben: | Callahan, Alfred ... Hennerici, Michael ... |
MARC
| LEADER | 00000caa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1634857666 | ||
| 003 | DE-627 | ||
| 005 | 20220816005658.0 | ||
| 007 | tu | ||
| 008 | 121106s2011 xx ||||| 00| ||eng c | ||
| 035 | |a (DE-627)1634857666 | ||
| 035 | |a (DE-576)373287380 | ||
| 035 | |a (DE-599)BSZ373287380 | ||
| 035 | |a (OCoLC)1341181615 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 245 | 0 | 0 | |a Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome |b secondary analysis of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial |c Callahan, Alfred ... Hennerici, Michael ... |
| 264 | 1 | |c 2011 | |
| 300 | |a 7 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ohne Hilfsmittel zu benutzen |b n |2 rdamedia | ||
| 338 | |a Band |b nc |2 rdacarrier | ||
| 700 | 1 | |a Callahan, Alfred |4 oth | |
| 700 | 1 | |a Hennerici, Michael G. |d 1948- |0 (DE-588)11587545X |0 (DE-627)077527704 |0 (DE-576)290126444 |4 oth | |
| 773 | 0 | 8 | |i In |t Archives of neurology |d Chicago, Ill. : American Medical Association, 1960 |g 68(2011), 10, Seite 1245-1251 |w (DE-627)129268704 |w (DE-600)80049-1 |w (DE-576)014459132 |x 0003-9942 |7 nnas |a Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome secondary analysis of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial |
| 773 | 1 | 8 | |g volume:68 |g year:2011 |g number:10 |g pages:1245-1251 |g extent:7 |a Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome secondary analysis of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial |
| 951 | |a AR | ||
| 992 | |a 20121106 | ||
| 993 | |a Article | ||
| 994 | |a 2011 | ||
| 998 | |g 11587545X |a Hennerici, Michael G. |m 11587545X:Hennerici, Michael G. |d 60000 |d 62700 |e 60000PH11587545X |e 62700PH11587545X |k 0/60000/ |k 1/60000/62700/ |p 11 | ||
| 999 | |a KXP-PPN1634857666 |e 3290473333 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"name":{"displayForm":["Callahan, Alfred ... Hennerici, Michael ..."]},"person":[{"display":"Callahan, Alfred","role":"oth","family":"Callahan","given":"Alfred"},{"display":"Hennerici, Michael G.","role":"oth","family":"Hennerici","given":"Michael G."}],"id":{"eki":["1634857666"]},"origin":[{"dateIssuedKey":"2011","dateIssuedDisp":"2011"}],"title":[{"title_sort":"Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome","subtitle":"secondary analysis of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trial","title":"Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome"}],"language":["eng"],"relHost":[{"title":[{"title_sort":"Archives of neurology","subtitle":"official organ of the American Neurological Association","title":"Archives of neurology"}],"pubHistory":["3.1960 - 69.2012"],"part":{"issue":"10","pages":"1245-1251","year":"2011","extent":"7","text":"68(2011), 10, Seite 1245-1251","volume":"68"},"type":{"bibl":"periodical"},"disp":"Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome secondary analysis of the stroke prevention by aggressive reduction in cholesterol levels (SPARCL) trialArchives of neurology","recId":"129268704","corporate":[{"display":"American Neurological Association","roleDisplay":"Herausgebendes Organ","role":"isb"},{"role":"isb","display":"American Medical Association","roleDisplay":"Herausgebendes Organ"}],"language":["eng"],"origin":[{"dateIssuedDisp":"1960-2012","publisher":"American Medical Association","dateIssuedKey":"1960","publisherPlace":"Chicago, Ill."}],"id":{"zdb":["80049-1"],"eki":["129268704"],"issn":["0003-9942"]},"name":{"displayForm":["publ. by American Medical Association. Chief ed. Fred Plum"]}}],"recId":"1634857666","physDesc":[{"extent":"7 S."}],"type":{"bibl":"article-journal"}} | ||
| SRT | |a RISKOFSTRO2011 | ||